Clinical Trials Directory

Trials / Completed

CompletedNCT00992888

Inflammation, Immune Activation and Portal Hypertension in Alcoholic Hepatitis

Inflammation, Immune Activation and Portal Hypertension in Alcoholic Hepatitis. A Pato-etiological Study With Focus on the Endotoxin Pathway.

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
60 (estimated)
Sponsor
University of Aarhus · Academic / Other
Sex
All
Age
18 Years – 69 Years
Healthy volunteers
Not accepted

Summary

The purpose of this study is to investigate the role of endotoxins and the endotoxin mediated immune activation pathway in patients with alcoholic hepatitis. Also, to determine the effect of Liver assist (liver dialyses) intervention on these parameters in patients with severe alcoholic hepatitis.

Conditions

Interventions

TypeNameDescription
DEVICEPrometheus Liver Dialysis system (Fresenius Medical Care)6 hour dialysis for 3 consecutive days

Timeline

Start date
2009-08-01
Primary completion
2011-09-01
Completion
2011-09-01
First posted
2009-10-09
Last updated
2011-09-15

Locations

1 site across 1 country: Denmark

Source: ClinicalTrials.gov record NCT00992888. Inclusion in this directory is not an endorsement.

Inflammation, Immune Activation and Portal Hypertension in Alcoholic Hepatitis (NCT00992888) · Clinical Trials Directory